Shelly Jain

Shelly Jain, MD

  • Ophthalmology

Appointments: (614) 293-8116

About Me

I'm an ophthalmologist specializing in glaucoma. I chose this specialty because I love the one-on-one relationships physicians have with their patients. I enjoy getting to know people and improving their quality of life.

I chose to work at Ohio State for many reasons. As an Ohio native, I take pride in our state and its people. When I was a medical student, a family member came to Ohio State and received excellent care. I was impressed with the physician’s ability and compassion. I wanted to be a part of that.

I've always appreciated how procedures like refraction and cataract surgery improve vision. But I was drawn to multifaceted ocular diseases, such as glaucoma. I enjoy the long-term relationships with patients and families as I work with them throughout their treatment.

Preventing vision loss is rewarding. I screen patients to see if they have early signs of glaucoma or other diseases. Early detection helps prevent vision loss.

My patients receive the best possible care. My goal is to give them a thorough eye exam, explain what’s going on, address any fears and answer all of their questions.

Highlights

  • Developing new targeted glaucoma therapies
  • Co-authored book chapters on glaucoma
  • Research interests include glaucoma, ocular hypertension and imaging
  • Best Doctor in America 2017

Specialties and conditions I treat

  • Ophthalmology
  • Eyelid Diseases
  • Diabetic Retinopathy
  • Ophthalmology
  • Optic Nerve Diseases
  • Eye Injuries
  • Hypertensive Retinopathy
  • Optic Nerve Injuries
  • Eye Hemorrhage
  • Endophthalmitis
  • Aphakia
  • Iridocyclitis
  • Iritis
  • Conjunctivitis, Bacterial
  • Hordeolum
  • Keratoconjunctivitis, Infectious
  • Conjunctivitis, Viral
  • Eye Pain
  • Photophobia
  • Optic Atrophy
  • Optic Disk Drusen
  • Optic Neuropathy, Ischemic
  • Papilledema
  • Aniridia
  • Exfoliation Syndrome
  • Iridocorneal Endothelial Syndrome
  • Optic Atrophies, Hereditary
  • Wolfram Syndrome
  • Optic Atrophy, Autosomal Dominant
  • Optic Atrophy, Hereditary, Leber
  • Glaucoma
  • Glaucoma, Angle-Closure
  • Glaucoma, Neovascular
  • Glaucoma, Open-Angle
  • Low Tension Glaucoma
  • Ocular Hypertension
  • Ocular Hypotension
  • Cataract

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

Education and training

Medical Degree

M.D.
Northeastern Ohio Universities College of Medicine
5/20/2006

Residency

Ophthalmology
Callahan Eye Foundation Hospital
7/1/2007 - 6/30/2010

My videos

More about my work

My background

Fellowship

Ophthalmology/Glaucoma
Wills Eye Hospital
7/1/2010 - 6/30/2011

Board Certification

American Board of Ophthalmology
10/16/2011

My Department

Ophthalmology

Reviews

263 Patient Satisfaction Reviews

The patient satisfaction rating is an average of all responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page
  • Overall
    4.8 out of 5
  • Explains Things Clearly 4.8
  • Listens Carefully 4.9
  • Gives Understandable Instructions 4.8
  • Knows My Medical History 4.7
  • Shows Respect 4.9
  • Time Spent Together 4.7

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Jain has reported no financial relationships with medical device, research and/or drug companies.